6c311e15_egy_Appendix___The_White_House__Action_Item_Description
[Action Item Number] 7.1.A [Action Item Name] Enhance the Drug Abuse Warning Network Emergency Department Data System [Lead Agency] HHS [Component(s)] SAMHSA [Action Item Description] 
DAWN provides national and local-area estimates of drug-related emergency department visits, and drug-related mortality. Read more This system is central for assessing the impact of drug use on the health care system and on the health of the population. The FDA, for example, uses DAWN as an indicator of potential side effects of previously approved prescription drugs. The system is not fully capable of meeting national and local needs and suffers from antiquated data collection procedures that do not provide timely results. SAMHSA will work with ONDCP and FDA to develop options to improve DAWN’s timeliness and its accuracy, including identifying agencies that rely on the data and could collaborate with SAMHSA to maintain DAWN’s viability.
ONDCP Strategy Appendix | The White House
Action Item Description